menu
    • menu

    Company profile for Kowa Company

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kowa operates globally across pharmaceuticals (specializing in metabolic/cardiovascular drugs), medical devices, energy solutions, and trading. Pioneers in lipid research, we developed the first PPAR modulator. Our healthcare division delivers innovative therapies while our environmental/energy businesses promote sustainability. With ISO-certified manufacturing and R&D spanning 20+ countries, we blend tradition with cutting-ed...
    Kowa operates globally across pharmaceuticals (specializing in metabolic/cardiovascular drugs), medical devices, energy solutions, and trading. Pioneers in lipid research, we developed the first PPAR modulator. Our healthcare division delivers innovative therapies while our environmental/energy businesses promote sustainability. With ISO-certified manufacturing and R&D spanning 20+ countries, we blend tradition with cutting-edge science to enhance lives worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kowa Companyjapan Flag
    Country
    Country
    Japan
    Address
    Address
    6-29, Nishiki 3-chome, Naka-ku, Nagoya, Aichi, 590-0982
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kowa.co.jp/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kowa initiates NCX 470 Phase 3 trial for Nicox in Japan
    Kowa initiates NCX 470 Phase 3 trial for Nicox in Japan

    05 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/05/3127028/0/en/Nicox-s-Partner-Kowa-Initiates-NCX-470-Phase-3-Clinical-Trial-in-Japan.html

    GLOBENEWSWIRE
    05 Aug 2025
    Share Share
    Nicox & Kowa Sign €191.5M Deal for NCX 470 Rights
    Nicox & Kowa Sign €191.5M Deal for NCX 470 Rights

    17 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/17/3116959/0/en/Nicox-and-Kowa-Sign-Key-Agreement-worth-up-to-191-5-million-for-Exclusive-Rights-to-Glaucoma-Treatment-NCX-470-in-U-S-and-all-Unlicensed-Territories.html

    GLOBENEWSWIRE
    17 Jul 2025
    Share Share
    K-679 Antibody Drug-loaded Unimicelle in EGFR-Expressing Tumors
    K-679 Antibody Drug-loaded Unimicelle in EGFR-Expressing Tumors

    21 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/k-679-a-novel-antibody-drug-loaded-unimicelle-conjugate-with-ultra-high-drug-loading-capacity-demonstrates-superior-efficacy-in-egfr-expressing-solid-tumors-302428078.html

    PR NEWSWIRE
    21 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search